INTRODUCTION
Familial Mediterranean fever (FMF) is an inherited disease characterized by recurrent inflammatory polyserositis. The disease is associated with a number of mutations of the MEFV gene. 1 FMF is typically expected only in the Middle East population; however, recently, this disease has been increasingly reported in non-Mediterranean regions. 2 Recurrent abdominal pain is a common symptom of FMF, being observed in approximately 90% of patients. 3 However, FMF is typically not familiar to clinicians in non-endemic areas and conventional diagnostic evaluations typically fail to detect FMF. Thus, it might be misdiagnosed as another gastrointestinal disease. 4 Various cutaneous features can also be seen during the course of FMF. 5, 6 Erysipelas like erythema is the well-known skin lesion. 5 On the other hand, FMF presenting as a urticarial eruption is rare. 6 We report on a case of FMF, which showed recurrent urticarial eruption and peripheral eosinophilia.
CASE REPORT
A 31-year-old male visited our hospital due to a 10-year history of recurrent, cramping abdominal pain, fever, and urticarial eruption. There was no family history of recurrent fever attack and abdominal pain. Typically, the abdominal pain, fever, and urticarial eruption had lasted for approximately three days and then resolved simultaneously and spontaneously. and erythrocyte sedimentation rate (13 mm/hr; reference rang,: 0-9 mm/hr) were found. Markers for autoimmune disease, including an anti-nuclear antibody and anti-neutrophil cytoplasmic antibody were negative. A peripheral blood cell morphology smear found no clues of other periodic fever diseases, such as malaria. Urinalysis was negative for protein and bacteria. The urticarial eruption broke out on the face, abdomen, back, and trunk and disappeared when fever and abdominal pain had subsided (Fig. 1 ).
We performed multiple biopsies in antrum, body, and fundus of gastric mucosa and ascending, transverse and descending colon as well as the rectum to rule out eosinophilic gastroenteritis. There was an elevated eosinophil count (up to 16 per high power field) in a degree that did not satisfy the diagnostic criteria for eosinophilic gastroenteritis. We also performed several tests to find any cause of peripheral eosinophilia, including stool parasite exam, multiple allergen screen test, peripheral blood cell morphology smear, and chest radiography. However, we failed to find any such cause of peripheral eosinophilia. 
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FMF with peripheral eosinophilia is not a common finding.
According to one previous report, active FMF patients showed an elevated eosinophil cationic protein level. 18 This finding suggests that eosinophil mediated inflammation and Th2 cells may play an important role in FMF pathogenesis. 18 In addition, one case report of MEFV gene mutations combined with eosinophilic gastritis has been reported. 19 In general, peripheral eosinophilia can be accompanied by parasitic infection, allergic reaction to drug, microscopic colitis, inflammatory bowel disease, and malignant lymphoma. In this case, we could exclude all of these diseases with history, physical examination, and several tests. Therefore, we assumed that peripheral eosinophilia in our patient may be associated with several lines of inflammatory cascade in active FMF.
In the current case, two complex mutations of p.Leu110Pro and p.Glu148Gln were noted. In previous studies, mutation of p.Leu110Pro was found mainly combined with p.Glu148Gln mutation. 8, 10, 20 According to one Japanese study, these types of mutations have been reported in 11.3% of FMF patients. 8 In addition, the same two point mutations were reported as FMF in Korea in 2012. 10 Although we could not confirm the inheritance pattern of the two mutant alleles due to the lack of family gene data, these Japanese data and Korean case suggested that our mutations are sufficient to express the typical symptoms of FMF.
Typical cutaneous lesion of FMF was characterized by warm, tender erysipelas-like erythema with well-defined borders located on the lower legs, medial malleolus, or the dorsum of the foot. 6 However, in this case, the eruption was found over the entire body and displayed wheal-like features.
In this case, abdominal pain, fever, and skin rash lasted for around three days and then subsided spontaneously. We consulted a dermatologist to take a biopsy of the skin lesion.
However, at the time of biopsy by a dermatologist, the skin rash had disappeared and we unfortunately failed in taking tissue to confirm. Although we did not confirm tissue biopsy, the patient's skin rash expressed typical features of a wheal like urticarial eruption.
DNA analysis of the MEFV gene mutation was requested to an outside specialized institution; the final result takes approximately two months. Although FMF was initially suspected, we did not have a trial of colchicine during a short attack because FMF is a very rare disease entity and we had a paucity of clinical experience regarding FMF. Thus, we did not confirm colchicine response in active FMF state. Our patient was recommended to receive oral colchicine (1.2 mg/day) to prevent attack of FMF. His symptoms did not recur for over one year during the follow up period. However, due to the short follow up duration, the protective effects of colchicine against attacks of FMF cannot be confirmed.
In conclusion, we report on an interesting case of a 31-year-old Korean man who manifested with fever, abdominal pain, and urticarial eruption and who was finally diagnosed as FMF through MEFV gene analysis. Suspicion and diagnosis of FMF is difficult in non-endemic areas. However, if unexplained recurrent abdominal pain accompanied with fever cannot be elucidated using conventional diagnostic tools, FMF should be considered as a potential cause in a non-endemic area like Korea.
